In the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT), on-treatment high-sensitivity C-reactive protein (hs-CRP) levels following statin treatment predicted subsequent cardiovascular risk reductions.

Authors

• Person: Not available Organization: National Lipid Association
  EBM Tools for Practice: Best Biomarkers for Inflammation

Sources

• EBM Tools for Practice: Best Biomarkers for Inflammation www.lipid.org National Lipid Association via serper

Referenced by nodes (2)

• high-sensitivity C-reactive protein concept
• cardiovascular risk factors concept